CD24 is a surrogate for ‘immune‐cold’ phenotype in aggressive large B‐cell lymphoma

The tumor microenvironment (TME) is a critical regulator of the development of malignant lymphoma. Therapeutics targeting the TME, especially immune checkpoint molecules, are changing the treatment strategy for lymphoma. However, the overall response to these therapeutics for diffuse large B‐cell ly...

Descripción completa

Detalles Bibliográficos
Autores principales: Higashi, Morihiro, Momose, Shuji, Takayanagi, Natsuko, Tanaka, Yuka, Anan, Tomoe, Yamashita, Takahisa, Kikuchi, Jun, Tokuhira, Michihide, Kizaki, Masahiro, Tamaru, Jun‐ichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9161324/
https://www.ncbi.nlm.nih.gov/pubmed/35289116
http://dx.doi.org/10.1002/cjp2.266

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9161324/
https://www.ncbi.nlm.nih.gov/pubmed/35289116
http://dx.doi.org/10.1002/cjp2.266

Ejemplares similares